| Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US5985321 | NOVARTIS | Soft gelatin capsule manufacture |
Sep, 2014
(9 years ago) | |
Neoral is owned by Novartis.
Neoral contains Cyclosporine.
Neoral has a total of 1 drug patent out of which 1 drug patent has expired.
Expired drug patents of Neoral are:
- US5985321
Neoral was authorised for market use on 14 July, 1995.
Neoral is available in capsule;oral, solution;oral dosage forms.
The generics of Neoral are possible to be released after 26 September, 2014.
Drugs and Companies using CYCLOSPORINE ingredient
Market Authorisation Date: 14 July, 1995
Treatment: NA
Dosage: CAPSULE;ORAL; SOLUTION;ORAL
More Information on Dosage
NEORAL family patents
